|
|
Drugs & Anaphylaxis
Purpose:
The Drugs & Anaphylaxis Committee monitors, provides recommendations to the Board of Regents and implements programs in the area of allergy and asthma pharmaceuticals and anaphylaxis.
Current projects include:
- Development of study concerning the use of epi-pens and management of drug reactions
Members:
Chair: Dana V. Wallace, MD (11/11)
Vice Chair: David A. Khan, MD (11/10)
| Terms expire 11/09: |
Terms expire 11/10: |
Terms expire 11/11: |
| Oner Ozdemir, MD |
Phillip Lieberman, MD |
Bernard Zeffren, MD |
| Mona Imam, MD |
Paul J. Dowling, MD |
Andrew Hope, MD |
| Peter Kao, MD |
Myngoc T. Nguyen, MD |
Sanaa Mahmoud, MD |
| Scott P. Cummins, MD (FIT) |
|
|
|
|
|
| Consultant: |
|
|
| Joanne Vitanza, MD (Verus) |
|
|
Committee Bulletin Board
|